Loading...
A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma
LESSONS LEARNED. Pazopanib shows a modest efficacy in metastatic alveolar soft part sarcoma. Clinical outcomes were comparable to those in previous studies using antiangiogenic drugs. Further prospective studies evaluating the benefit of pazopanib in alveolar soft part sarcoma with a larger sample a...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6324645/ https://ncbi.nlm.nih.gov/pubmed/30254189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0464 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|